Showing results (171-180 of 224) with videos related to

Sort By:
Pageof 23
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 16, 2019
Rapid Clearance Profile of Plasma Circulating Tumor HPV Type 16 DNA during Chemoradiotherapy Correlates with Disease Control in HPV-Associated Oropharyngeal CancerBhishamjit S Chera, Sunil Kumar, Brian T Beaty, et al.
Cancer Research Communications|September 23, 2022
Tumor Cell Extrinsic Synaptogyrin 3 Expression as a Diagnostic and Prognostic Biomarker in Head and Neck CancerRyan M Murphy, Jason Tasoulas, Alessandro Porrello, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 7, 2020
Concurrent Definitive Immunoradiotherapy for Patients with Stage III-IV Head and Neck Cancer and Cisplatin ContraindicationJared Weiss, Siddharth Sheth, Allison M Deal, et al.
ACS Pharmacology & Translational Science|October 19, 2020
Torin 2 Derivative, NCATS-SM3710, Has Potent Multistage Antimalarial Activity through Inhibition of P. falciparum Phosphatidylinositol 4-Kinase (Pf PI4KIIIβ)Karthik Krishnan, Peter Ziniel, Hao Li, et al.
Journal of Translational Medicine|December 17, 2022
Integrated multi-omic analysis of low-grade ovarian serous carcinoma collected from short and long-term survivorsKwong-Kwok Wong, Nicholas W Bateman, Chun Wai Ng, et al.
Iscience|March 5, 2024
ProteoMixture: A cell type deconvolution tool for bulk tissue proteomic dataPang-Ning Teng, Joshua P Schaaf, Tamara Abulez, et al.
Cell Reports. Medicine|November 17, 2022
Proteogenomic analysis of lung adenocarcinoma reveals tumor heterogeneity, survival determinants, and therapeutically relevant pathwaysAnthony R Soltis, Nicholas W Bateman, Jianfang Liu, et al.
Elife|July 1, 2022
Response to immune checkpoint blockade improved in pre-clinical model of breast cancer after bariatric surgeryLaura M Sipe, Mehdi Chaib, Emily B Korba, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 4, 2022
A Randomized Multi-institutional Phase II Trial of Everolimus as Adjuvant Therapy in Patients with Locally Advanced Squamous Cell Cancer of the Head and NeckCherie-Ann O Nathan, D Neil Hayes, Theodore Karrison, et al.
Cell Reports|June 23, 2021
Immune checkpoint blockade reprograms systemic immune landscape and tumor microenvironment in obesity-associated breast cancerAjeeth K Pingili, Mehdi Chaib, Laura M Sipe, et al.
Pageof 23